首页 > 最新文献

BMC Pediatrics最新文献

英文 中文
Functional analysis of heterozygous variants in the SALL1 gene in 2 children with Townes-Brocks syndrome with FSGS.
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2025-02-05 DOI: 10.1186/s12887-024-05326-5
Rong Liang, Bixia Zheng, Chunli Wang, Sanlong Zhao, Wei Zhou, Ying Chen, Ruochen Che

Background: To investigate the functional characteristics of heterozygous variants in the SALL1 gene in two children with Townes-Brocks syndrome (TBS), as well as the underlying mechanisms leading to chronic kidney disease.

Methods: We retrospectively analyzed the clinical manifestations, laboratory findings, and genetic backgrounds of two TBS patients admitted to our hospital presenting with chronic kidney disease stage 2 and focal segmental glomerulosclerosis (FSGS). The genetic function was investigated through cultured cells transfected with variants. The Sall1 protein expression level was detected by western blotting. Immunofluorescence was also employed to detect the subcellular localization of SALL1.

Results: Novel heterozygous genetic variations (c.3175 C > T and c.694 C > T) were detected in two respective probands with distinct clinical presentations: Proband 1 presented with polydactyly, nephrotic syndrome, and stage 2 chronic kidney disease; while Proband 2 manifested renal dysplasia, progressive proteinuria, and also stage 2 chronic kidney disease. FSGS was confirmed by kidney biopsies from both probands. To assess the functional impact of these variations, we introduced mutant plasmids carrying the c.3175 C > T and c.694 C > T variants into podocytes. The expression level of variant c.3175 C > T(p.Q1059X) in podocytes showed a significant decrease compared to that of the wild-type (P < 0.05), whereas variant c.694 C > T(p.Q232X) was markedly upregulated (P < 0.01). Immunofluorescence analysis revealed aberrant localization patterns for both SALL1 variants within podocytes.

Conclusions: Two patients with Townes-Brocks syndrome (TBS) harboring novel variants presented atypical phenotypes, characterized primarily by significant and rapidly progressing renal involvement. Rare renal biopsy pathology revealed the presence of focal segmental glomerulosclerosis (FSGS) in both cases. Experimental validation demonstrated that both variants led to alterations in the molecular size, expression level, and localization of the Sall1 protein, suggesting that these SALL1 gene variants might contribute to FSGS by impacting podocyte function.

{"title":"Functional analysis of heterozygous variants in the SALL1 gene in 2 children with Townes-Brocks syndrome with FSGS.","authors":"Rong Liang, Bixia Zheng, Chunli Wang, Sanlong Zhao, Wei Zhou, Ying Chen, Ruochen Che","doi":"10.1186/s12887-024-05326-5","DOIUrl":"https://doi.org/10.1186/s12887-024-05326-5","url":null,"abstract":"<p><strong>Background: </strong>To investigate the functional characteristics of heterozygous variants in the SALL1 gene in two children with Townes-Brocks syndrome (TBS), as well as the underlying mechanisms leading to chronic kidney disease.</p><p><strong>Methods: </strong>We retrospectively analyzed the clinical manifestations, laboratory findings, and genetic backgrounds of two TBS patients admitted to our hospital presenting with chronic kidney disease stage 2 and focal segmental glomerulosclerosis (FSGS). The genetic function was investigated through cultured cells transfected with variants. The Sall1 protein expression level was detected by western blotting. Immunofluorescence was also employed to detect the subcellular localization of SALL1.</p><p><strong>Results: </strong>Novel heterozygous genetic variations (c.3175 C > T and c.694 C > T) were detected in two respective probands with distinct clinical presentations: Proband 1 presented with polydactyly, nephrotic syndrome, and stage 2 chronic kidney disease; while Proband 2 manifested renal dysplasia, progressive proteinuria, and also stage 2 chronic kidney disease. FSGS was confirmed by kidney biopsies from both probands. To assess the functional impact of these variations, we introduced mutant plasmids carrying the c.3175 C > T and c.694 C > T variants into podocytes. The expression level of variant c.3175 C > T(p.Q1059X) in podocytes showed a significant decrease compared to that of the wild-type (P < 0.05), whereas variant c.694 C > T(p.Q232X) was markedly upregulated (P < 0.01). Immunofluorescence analysis revealed aberrant localization patterns for both SALL1 variants within podocytes.</p><p><strong>Conclusions: </strong>Two patients with Townes-Brocks syndrome (TBS) harboring novel variants presented atypical phenotypes, characterized primarily by significant and rapidly progressing renal involvement. Rare renal biopsy pathology revealed the presence of focal segmental glomerulosclerosis (FSGS) in both cases. Experimental validation demonstrated that both variants led to alterations in the molecular size, expression level, and localization of the Sall1 protein, suggesting that these SALL1 gene variants might contribute to FSGS by impacting podocyte function.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":"25 1","pages":"99"},"PeriodicalIF":2.0,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143254780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study.
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2025-02-05 DOI: 10.1186/s12887-024-05313-w
Mohammed Hasosah, Ghassan Sukkar, Asharf AlSahafi, Ali Zaidan, Nouf Ghous, Abdulmajed Alshahrani, Ziyad Al Zahrani, Naif Hasosah, Mansour Qurashi, Loie Goronfolah, Ali Alsharief, Nagla Kamal

Background: Eosinophilic esophagitis (EoE) is a chronic inflammatory disorder characterized by symptoms of esophageal dysfunction and eosinophil-predominant inflammation. Dupilumab is a human monoclonal antibody that targets both IL-4 and IL-13 signaling. It is currently indicated for the treatment of asthma, atopic dermatitis, and EoE. This study aimed to describe children with EoE that is difficult to treat using conventional treatment and to identify symptomatic, histological, and endoscopic improvements after dupilumab treatment.

Materials and methods: We conducted a retrospective multicenter study in children with confirmed EoE and performed a chart review of patients prescribed dupilumab for EoE. Demographic information, symptoms, and medications including dupilumab treatment were collected. The endoscopic findings, histopathological features, and treatment results were analyzed. We calculated the change in EoE endoscopic reference scoring system (EREFS) scores from the baseline to 3 months.

Results: Eleven patients were included in this study. The study population comprised seven boys (64%) and four girls (36%). The median age at presentation was 11.6 years (8-13 years). Dupilumab at a dose of 200-300 mg was administered to all patients as second-line therapy for children with EoE refractory to conventional therapy (proton pump inhibitors, corticosteroids, and dietary restrictions). Dupilumab efficacy regarding symptom relief, and endoscopic and histological improvements was 82%, 73%, and 90%, respectively. The mean EoE endoscopic reference scoring system scores changed from a baseline of 6.9 (before dupilumab) to 0.3 (after dupilumab). In addition to the improvement in EoE, the use of corticosteroids in EoE and inhaled corticosteroids in asthma was decreased for all patients, suggesting that dupilumab may be effective in patients with multiple concurrent atopic conditions. Dupilumab had a well-tolerated safety profile, except for one patient who developed conjunctivitis.

Conclusion: This pediatric study demonstrates the effectiveness of dupilumab as a second-line therapy for symptom relief, and endoscopic and histological improvements of EoE that is refractory to current treatment. A longitudinal, large prospective study is necessary to guide the initiation of dupilumab treatment for childhood EoE, and long-term follow-up data on dupilumab are required.

Clinical trial number: Not applicable.

{"title":"Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study.","authors":"Mohammed Hasosah, Ghassan Sukkar, Asharf AlSahafi, Ali Zaidan, Nouf Ghous, Abdulmajed Alshahrani, Ziyad Al Zahrani, Naif Hasosah, Mansour Qurashi, Loie Goronfolah, Ali Alsharief, Nagla Kamal","doi":"10.1186/s12887-024-05313-w","DOIUrl":"https://doi.org/10.1186/s12887-024-05313-w","url":null,"abstract":"<p><strong>Background: </strong>Eosinophilic esophagitis (EoE) is a chronic inflammatory disorder characterized by symptoms of esophageal dysfunction and eosinophil-predominant inflammation. Dupilumab is a human monoclonal antibody that targets both IL-4 and IL-13 signaling. It is currently indicated for the treatment of asthma, atopic dermatitis, and EoE. This study aimed to describe children with EoE that is difficult to treat using conventional treatment and to identify symptomatic, histological, and endoscopic improvements after dupilumab treatment.</p><p><strong>Materials and methods: </strong>We conducted a retrospective multicenter study in children with confirmed EoE and performed a chart review of patients prescribed dupilumab for EoE. Demographic information, symptoms, and medications including dupilumab treatment were collected. The endoscopic findings, histopathological features, and treatment results were analyzed. We calculated the change in EoE endoscopic reference scoring system (EREFS) scores from the baseline to 3 months.</p><p><strong>Results: </strong>Eleven patients were included in this study. The study population comprised seven boys (64%) and four girls (36%). The median age at presentation was 11.6 years (8-13 years). Dupilumab at a dose of 200-300 mg was administered to all patients as second-line therapy for children with EoE refractory to conventional therapy (proton pump inhibitors, corticosteroids, and dietary restrictions). Dupilumab efficacy regarding symptom relief, and endoscopic and histological improvements was 82%, 73%, and 90%, respectively. The mean EoE endoscopic reference scoring system scores changed from a baseline of 6.9 (before dupilumab) to 0.3 (after dupilumab). In addition to the improvement in EoE, the use of corticosteroids in EoE and inhaled corticosteroids in asthma was decreased for all patients, suggesting that dupilumab may be effective in patients with multiple concurrent atopic conditions. Dupilumab had a well-tolerated safety profile, except for one patient who developed conjunctivitis.</p><p><strong>Conclusion: </strong>This pediatric study demonstrates the effectiveness of dupilumab as a second-line therapy for symptom relief, and endoscopic and histological improvements of EoE that is refractory to current treatment. A longitudinal, large prospective study is necessary to guide the initiation of dupilumab treatment for childhood EoE, and long-term follow-up data on dupilumab are required.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":"25 1","pages":"100"},"PeriodicalIF":2.0,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143254773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Individual physical activity preferences of adolescents in the Czech Republic and Poland: a 14-year comparative study reflecting the gender trends and prospective responses to global lifestyle challenges.
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2025-02-05 DOI: 10.1186/s12887-024-05342-5
Michal Kudlacek, Karel Fromel, Dorota Groffik, Josef Mitas

Background: The global decline in physical activity (PA) among the youth has been exacerbated by the pandemic's impact on their lifestyles. Addressing these adverse effects post-pandemic by supporting preferred physical activities among young individuals is crucial. The aim of the study is to investigate and compare the long-term trends in PA preferences among individuals in Poland and the Czech Republic, exploring the impact of global lifestyle challenges over the past 14 years, including the pandemic, on PA behaviors and choices.

Methods: The study design is cross-sectional and data gathering was in the period between 2007 and 2020, this research encompassed 19,235 participants aged 15 to 26. PA preferences were gauged using the Questionnaire on Physical Activity Preferences, while actual PA levels were measured through the International Physical Activity Questionnaire-Long Form. Crossing table, Kruskal-Wallis ANOVA, binary logistic regression and effect size coefficients were conducted.

Results: Among the participants, individual physical activities were favoured by 24% of Czech and 25% of Polish boys, and 23% of Czech and 25% of Polish girls. A positive correlation was found between the preference for running and higher levels of recreational, vigorous, and overall weekly PA. Additionally, an increased preference for running was associated with a higher likelihood of meeting weekly PA recommendations for both girls (OR = 1.82, CI = 1.62-2.04, p < 0.001) and boys (OR = 1.61, CI = 1.44-1.82, p < 0.001) in both countries.

Conclusions: Over a 14-year period, swimming, cycling, and running emerged as the most preferred PA across both Czech and Polish youth, with a notable increase in running, especially among Czech boys. Polish boys and girls also showed a growing preference for running, while Polish girls demonstrated a notable increase in badminton and ice-skating. The preference for running was associated with a higher likelihood of meeting PA recommendations, especially among Polish boys and Czech girls. Notably, activities like running, swimming, and cycling exhibited resilience to both pandemic-related restrictions and broader global lifestyle challenges, underscoring the importance of long-term monitoring of PA preferences for effective health promotion.

{"title":"Individual physical activity preferences of adolescents in the Czech Republic and Poland: a 14-year comparative study reflecting the gender trends and prospective responses to global lifestyle challenges.","authors":"Michal Kudlacek, Karel Fromel, Dorota Groffik, Josef Mitas","doi":"10.1186/s12887-024-05342-5","DOIUrl":"https://doi.org/10.1186/s12887-024-05342-5","url":null,"abstract":"<p><strong>Background: </strong>The global decline in physical activity (PA) among the youth has been exacerbated by the pandemic's impact on their lifestyles. Addressing these adverse effects post-pandemic by supporting preferred physical activities among young individuals is crucial. The aim of the study is to investigate and compare the long-term trends in PA preferences among individuals in Poland and the Czech Republic, exploring the impact of global lifestyle challenges over the past 14 years, including the pandemic, on PA behaviors and choices.</p><p><strong>Methods: </strong>The study design is cross-sectional and data gathering was in the period between 2007 and 2020, this research encompassed 19,235 participants aged 15 to 26. PA preferences were gauged using the Questionnaire on Physical Activity Preferences, while actual PA levels were measured through the International Physical Activity Questionnaire-Long Form. Crossing table, Kruskal-Wallis ANOVA, binary logistic regression and effect size coefficients were conducted.</p><p><strong>Results: </strong>Among the participants, individual physical activities were favoured by 24% of Czech and 25% of Polish boys, and 23% of Czech and 25% of Polish girls. A positive correlation was found between the preference for running and higher levels of recreational, vigorous, and overall weekly PA. Additionally, an increased preference for running was associated with a higher likelihood of meeting weekly PA recommendations for both girls (OR = 1.82, CI = 1.62-2.04, p < 0.001) and boys (OR = 1.61, CI = 1.44-1.82, p < 0.001) in both countries.</p><p><strong>Conclusions: </strong>Over a 14-year period, swimming, cycling, and running emerged as the most preferred PA across both Czech and Polish youth, with a notable increase in running, especially among Czech boys. Polish boys and girls also showed a growing preference for running, while Polish girls demonstrated a notable increase in badminton and ice-skating. The preference for running was associated with a higher likelihood of meeting PA recommendations, especially among Polish boys and Czech girls. Notably, activities like running, swimming, and cycling exhibited resilience to both pandemic-related restrictions and broader global lifestyle challenges, underscoring the importance of long-term monitoring of PA preferences for effective health promotion.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":"25 1","pages":"98"},"PeriodicalIF":2.0,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143254791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lactate/albumin ratio as a prognostic biomarker for in-hospital mortality in pediatric patients with necrotizing enterocolitis.
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2025-02-04 DOI: 10.1186/s12887-025-05439-5
Ban Li, Yuanzhi Chen, Zhen Yang, Xianglun Sun, Cheng Tian, Jingsi Liu, Lihua Yuan, Kanglin Dai

Objective: To assess the lactate/albumin ratio (L/A) as a prognostic biomarker for differentiating in-hospital mortality risk in pediatric patients with necrotizing enterocolitis (NEC).

Methods: We performed a retrospective study utilizing the Pediatric Intensive Care (PIC) database. Patients diagnosed with NEC were categorized into a discharge group and a death group based on in-hospital outcomes. The association between L/A and in-hospital mortality was assessed using logistic regression models.

Results: After inclusion and exclusion criteria, 100 NEC patients were included in the study, with 87 survivors and 13 deaths. The mean age at admission was 21.6 ± 2.4 days, and the mean weight was 2.1 ± 0.1 kg. Significant differences in creatinine, international normalized ratio (INR) and L/A were observed between the groups (p < 0.05). The L/A ratio was a substantial predictor of in-hospital mortality, with an odds ratio (OR) of 5.24 (95% CI: 1.51-18.20, p = 0.01). An L/A cutoff value of 0.56 demonstrated a sensitivity of 0.923 and specificity of 0.486, with an AUC of 0.725 from the ROC curve analysis. Patients with an L/A ratio of ≥ 0.56 had a higher risk of in-hospital mortality (OR = 11.35, 95% CI: 1.40-91.93, p = 0.02).

Conclusion: Our study suggested that the L/A ratio may serve as a reliable prognostic indicator for in-hospital mortality in NEC. However, given the limitations of our research, more prospective studies are still needed in the future to test the predictive value of L/A ratio for the prognosis of NEC disease.

Clinical trial number: Not applicable.

{"title":"Lactate/albumin ratio as a prognostic biomarker for in-hospital mortality in pediatric patients with necrotizing enterocolitis.","authors":"Ban Li, Yuanzhi Chen, Zhen Yang, Xianglun Sun, Cheng Tian, Jingsi Liu, Lihua Yuan, Kanglin Dai","doi":"10.1186/s12887-025-05439-5","DOIUrl":"https://doi.org/10.1186/s12887-025-05439-5","url":null,"abstract":"<p><strong>Objective: </strong>To assess the lactate/albumin ratio (L/A) as a prognostic biomarker for differentiating in-hospital mortality risk in pediatric patients with necrotizing enterocolitis (NEC).</p><p><strong>Methods: </strong>We performed a retrospective study utilizing the Pediatric Intensive Care (PIC) database. Patients diagnosed with NEC were categorized into a discharge group and a death group based on in-hospital outcomes. The association between L/A and in-hospital mortality was assessed using logistic regression models.</p><p><strong>Results: </strong>After inclusion and exclusion criteria, 100 NEC patients were included in the study, with 87 survivors and 13 deaths. The mean age at admission was 21.6 ± 2.4 days, and the mean weight was 2.1 ± 0.1 kg. Significant differences in creatinine, international normalized ratio (INR) and L/A were observed between the groups (p < 0.05). The L/A ratio was a substantial predictor of in-hospital mortality, with an odds ratio (OR) of 5.24 (95% CI: 1.51-18.20, p = 0.01). An L/A cutoff value of 0.56 demonstrated a sensitivity of 0.923 and specificity of 0.486, with an AUC of 0.725 from the ROC curve analysis. Patients with an L/A ratio of ≥ 0.56 had a higher risk of in-hospital mortality (OR = 11.35, 95% CI: 1.40-91.93, p = 0.02).</p><p><strong>Conclusion: </strong>Our study suggested that the L/A ratio may serve as a reliable prognostic indicator for in-hospital mortality in NEC. However, given the limitations of our research, more prospective studies are still needed in the future to test the predictive value of L/A ratio for the prognosis of NEC disease.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":"25 1","pages":"93"},"PeriodicalIF":2.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143188277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of sleep problems in patients with Kawasaki disease: a survey-based study.
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2025-02-04 DOI: 10.1186/s12887-025-05418-w
Samar Tharwat, Mohammed Kamal Nassar

Introduction: Kawasaki disease (KD) is a rare systemic inflammatory disease that primarily affects children under the age of five. It is now recognized as the most prevalent cause of acquired heart diseases in children in developed countries.

Objectives: The aim of this study was to evaluate sleep disturbances in patients with KD and identify their prevalence and associations.

Methods: This cross-sectional analytic survey-based study was carried out on 262 participants (130 KD patients and 132 age- and sex-matched healthy controls). Participants were invited via social media groups. Sociodemographic data, clinical characteristics and therapeutic data of KD patients were collected. To identify the presence of sleep disturbances, all participants completed Children's Sleep Habits Questionnaire (CSHQ).

Results: The median age for KD patients was 6 years, and 51.5% of them were female, the median age at disease onset was 2.5 years, and the median disease duration was 3 years. The sleep scores of patients with KD were significantly higher than those of the control group (55.72 ± 11.97 vs. 49.45 ± 8.54, p < 0.001). The total duration of sleep did not exhibit any statistically significant difference between patients with KD and healthy controls (p = 0.399). KD patients exhibited significantly elevated scores in sleep onset delay, sleep duration, night wakings, parasomnias, and sleep-disordered breathing (p < 0.001). Additionally, they showed marginally higher scores in daytime sleepiness (p = 0.059). Younger age of KD patients was associated with higher rates of bedtime resistance (p < 0.001) and sleep anxiety (p = 0.005). Younger age at KD onset was associated significantly with higher rates of bedtime resistance (p = 0.009), sleep anxiety (p = 0.038), night wakings (p = 0.017), and worse sleep quality (p = 0.033). KD Patients who exhibited lethargy, and received corticosteroid medication had significantly higher sleep scores than those who did not.

Conclusion: Patients with KD experience higher sleep disturbance than their healthy counterparts. Young age, early disease onset, lethargy and corticosteroid administration are linked to poor sleep quality.

导言:川崎病(KD)是一种罕见的全身性炎症性疾病,主要影响五岁以下儿童。在发达国家,川崎病现已被公认为导致儿童后天性心脏病的最主要原因:本研究旨在评估 KD 患者的睡眠障碍,并确定其发病率和相关性:这项横断面分析调查研究的对象为 262 名参与者(130 名 KD 患者和 132 名年龄和性别匹配的健康对照者)。参与者是通过社交媒体群组邀请的。研究收集了 KD 患者的社会人口学数据、临床特征和治疗数据。为了确定是否存在睡眠障碍,所有参与者都填写了儿童睡眠习惯问卷(CSHQ):KD患者的中位年龄为6岁,51.5%为女性,中位发病年龄为2.5岁,中位病程为3年。KD患者的睡眠评分明显高于对照组(55.72±11.97 vs. 49.45±8.54,P 结论:KD患者的睡眠障碍程度高于对照组(55.72±11.97 vs. 49.45±8.54,P 结论:KD患者的睡眠障碍程度高于对照组:与健康人相比,KD 患者的睡眠障碍程度更高。年龄小、发病早、嗜睡和皮质类固醇用药与睡眠质量差有关。
{"title":"Assessment of sleep problems in patients with Kawasaki disease: a survey-based study.","authors":"Samar Tharwat, Mohammed Kamal Nassar","doi":"10.1186/s12887-025-05418-w","DOIUrl":"10.1186/s12887-025-05418-w","url":null,"abstract":"<p><strong>Introduction: </strong>Kawasaki disease (KD) is a rare systemic inflammatory disease that primarily affects children under the age of five. It is now recognized as the most prevalent cause of acquired heart diseases in children in developed countries.</p><p><strong>Objectives: </strong>The aim of this study was to evaluate sleep disturbances in patients with KD and identify their prevalence and associations.</p><p><strong>Methods: </strong>This cross-sectional analytic survey-based study was carried out on 262 participants (130 KD patients and 132 age- and sex-matched healthy controls). Participants were invited via social media groups. Sociodemographic data, clinical characteristics and therapeutic data of KD patients were collected. To identify the presence of sleep disturbances, all participants completed Children's Sleep Habits Questionnaire (CSHQ).</p><p><strong>Results: </strong>The median age for KD patients was 6 years, and 51.5% of them were female, the median age at disease onset was 2.5 years, and the median disease duration was 3 years. The sleep scores of patients with KD were significantly higher than those of the control group (55.72 ± 11.97 vs. 49.45 ± 8.54, p < 0.001). The total duration of sleep did not exhibit any statistically significant difference between patients with KD and healthy controls (p = 0.399). KD patients exhibited significantly elevated scores in sleep onset delay, sleep duration, night wakings, parasomnias, and sleep-disordered breathing (p < 0.001). Additionally, they showed marginally higher scores in daytime sleepiness (p = 0.059). Younger age of KD patients was associated with higher rates of bedtime resistance (p < 0.001) and sleep anxiety (p = 0.005). Younger age at KD onset was associated significantly with higher rates of bedtime resistance (p = 0.009), sleep anxiety (p = 0.038), night wakings (p = 0.017), and worse sleep quality (p = 0.033). KD Patients who exhibited lethargy, and received corticosteroid medication had significantly higher sleep scores than those who did not.</p><p><strong>Conclusion: </strong>Patients with KD experience higher sleep disturbance than their healthy counterparts. Young age, early disease onset, lethargy and corticosteroid administration are linked to poor sleep quality.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":"25 1","pages":"96"},"PeriodicalIF":2.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143188238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insulin autoimmune syndrome in a 3-year-old boy: the youngest to date in China and a narrow review.
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2025-02-04 DOI: 10.1186/s12887-025-05395-0
Ming Cheng, Yuan Ding, Dongmei Wang, Chunxiu Gong

Background: Insulin autoimmune syndrome (IAS), characterized by endogenous hypoglycemia associated with insulin autoantibodies, is a rare cause of hypoglycemia in pediatric patients. Here, we report a case of the youngest patient with IAS in China, and summarize the clinical characteristics of the disease through a narrow review of pediatric cases.

Case presentation: A 3-year-10-month-old Chinese boy presented with unconsciousness. Initially, he was misdiagnosed with hyperinsulinemic hypoglycemia (HH) due to non-ketotic hypoglycemia. Whole exome sequencing (WES) was negative, and no pancreatic space-occupying lesions were identified. He continued to have intermittent episodes of symptomatic hypoglycemia. During an extended oral glucose tolerance test (OGTT), his insulin to C-peptide molar ratio was greater than 1, and anti-insulin antibodies (IAAs) measurements were as high as 54.38 COI (normal range 0-1 COI). High-resolution human leukocyte antigen (HLA) test showed a DRB1*08:03/*12:02 genotype. He was eventually diagnosed with IAS. Hypoglycemic episodes were not observed as long as the patient adhered to the low and frequent carbohydrate diet. Six months later, the patient's anti-insulin antibody had decreased to 10.17 COI, and mildly symptomatic hypoglycemia occasionally occurred in the case of noncompliance with the diet. Based on 11 studies from a literature review and our own case, a total of 12 pediatric patients were analyzed. Most of these patients presented with unconsciousness initially and their episodes of hypoglycemia do not follow a definitive pattern. Adjustments in diet serve as an effective intervention, and spontaneous remission is relatively common.

Conclusion: When differentiating the causes of HH in pediatric patients, IAS should not be overlooked. Elevated levels of IAAs and an inappropriate insulin to C-peptide molar ratio during an extended OGTT are critical indicators.

Clinical trial number: Not applicable.

{"title":"Insulin autoimmune syndrome in a 3-year-old boy: the youngest to date in China and a narrow review.","authors":"Ming Cheng, Yuan Ding, Dongmei Wang, Chunxiu Gong","doi":"10.1186/s12887-025-05395-0","DOIUrl":"10.1186/s12887-025-05395-0","url":null,"abstract":"<p><strong>Background: </strong>Insulin autoimmune syndrome (IAS), characterized by endogenous hypoglycemia associated with insulin autoantibodies, is a rare cause of hypoglycemia in pediatric patients. Here, we report a case of the youngest patient with IAS in China, and summarize the clinical characteristics of the disease through a narrow review of pediatric cases.</p><p><strong>Case presentation: </strong>A 3-year-10-month-old Chinese boy presented with unconsciousness. Initially, he was misdiagnosed with hyperinsulinemic hypoglycemia (HH) due to non-ketotic hypoglycemia. Whole exome sequencing (WES) was negative, and no pancreatic space-occupying lesions were identified. He continued to have intermittent episodes of symptomatic hypoglycemia. During an extended oral glucose tolerance test (OGTT), his insulin to C-peptide molar ratio was greater than 1, and anti-insulin antibodies (IAAs) measurements were as high as 54.38 COI (normal range 0-1 COI). High-resolution human leukocyte antigen (HLA) test showed a DRB1*08:03/*12:02 genotype. He was eventually diagnosed with IAS. Hypoglycemic episodes were not observed as long as the patient adhered to the low and frequent carbohydrate diet. Six months later, the patient's anti-insulin antibody had decreased to 10.17 COI, and mildly symptomatic hypoglycemia occasionally occurred in the case of noncompliance with the diet. Based on 11 studies from a literature review and our own case, a total of 12 pediatric patients were analyzed. Most of these patients presented with unconsciousness initially and their episodes of hypoglycemia do not follow a definitive pattern. Adjustments in diet serve as an effective intervention, and spontaneous remission is relatively common.</p><p><strong>Conclusion: </strong>When differentiating the causes of HH in pediatric patients, IAS should not be overlooked. Elevated levels of IAAs and an inappropriate insulin to C-peptide molar ratio during an extended OGTT are critical indicators.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":"25 1","pages":"94"},"PeriodicalIF":2.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143188274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations between media parenting practices and early adolescent consumption of R-rated movies and mature-rated video games. 媒体教养方式与青少年早期消费 R 级电影和成熟级电子游戏之间的关系。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2025-02-04 DOI: 10.1186/s12887-024-05367-w
Jason M Nagata, Karen Li, Shirley S Sui, Jonanne Talebloo, Christopher D Otmar, Iris Yuefan Shao, Orsolya Kiss, Kyle T Ganson, Alexander Testa, Jinbo He, Fiona C Baker

Objective: To assess whether specific parent media practices are associated with the consumption of R-rated (restricted) movies and mature-rated video game use in early adolescents.

Methods: Data from the Adolescent Brain Cognitive Development (ABCD) Study (N = 10,054, 12-13 years, Year 3, 2019-2021) were analyzed. Ordinal logistic regression models were used to assess associations among media parenting practices and R-rated movies or mature-rated video game use, adjusting for potential confounders.

Results: Parental allowance of bedroom screen use (adjusted odds ratio [AOR] 1.44, 95% confidence interval [CI] 1.36-1.53), family mealtime screen use (AOR 1.19, 95% CI 1.13-1.25), and parent screen use (AOR 1.11, 95% CI 1.03-1.20) were positively associated with watching R-rated movies. Parental allowance of bedroom screen use (AOR 1.44, 95% CI 1.36-1.52), family mealtime screen use (AOR 1.26, 95% CI 1.19-1.32), and parent screen use (AOR 1.11, 95% CI 1.02-1.20) were positively associated with playing mature-rated video games. Greater parental monitoring and limiting of screen time were negatively associated with watching R-rated movies (AOR 0.81, 95% CI 0.77-0.85 and AOR 0.73, 95% CI 0.68-0.79 respectively) and playing mature-rated video games (AOR 0.81, 95% CI 0.77-0.86 and AOR 0.72, 95% CI 0.67-0.77). Restricting screen time as a punishment for misbehavior was linked to a higher odds of watching R-rated movies (AOR 1.06, 95% CI 1.01-1.11) and playing mature-rated video games (AOR 1.12, 95% CI 1.07-1.17) while offering screen time to reward for good behavior was negatively associated with watching R-rated movies (AOR 0.95, 95% CI 0.90-0.99).

Conclusions: Media parenting practices such as monitoring or limiting screen use are significantly associated with playing mature-rated video games and watching R-rated movies. Punitive measures, such as restricting screen time as a punishment are slightly associated with increased engagement with such content. These findings highlight the importance of intentional and thoughtful parental strategies in managing children's media consumption effectively.

{"title":"Associations between media parenting practices and early adolescent consumption of R-rated movies and mature-rated video games.","authors":"Jason M Nagata, Karen Li, Shirley S Sui, Jonanne Talebloo, Christopher D Otmar, Iris Yuefan Shao, Orsolya Kiss, Kyle T Ganson, Alexander Testa, Jinbo He, Fiona C Baker","doi":"10.1186/s12887-024-05367-w","DOIUrl":"https://doi.org/10.1186/s12887-024-05367-w","url":null,"abstract":"<p><strong>Objective: </strong>To assess whether specific parent media practices are associated with the consumption of R-rated (restricted) movies and mature-rated video game use in early adolescents.</p><p><strong>Methods: </strong>Data from the Adolescent Brain Cognitive Development (ABCD) Study (N = 10,054, 12-13 years, Year 3, 2019-2021) were analyzed. Ordinal logistic regression models were used to assess associations among media parenting practices and R-rated movies or mature-rated video game use, adjusting for potential confounders.</p><p><strong>Results: </strong>Parental allowance of bedroom screen use (adjusted odds ratio [AOR] 1.44, 95% confidence interval [CI] 1.36-1.53), family mealtime screen use (AOR 1.19, 95% CI 1.13-1.25), and parent screen use (AOR 1.11, 95% CI 1.03-1.20) were positively associated with watching R-rated movies. Parental allowance of bedroom screen use (AOR 1.44, 95% CI 1.36-1.52), family mealtime screen use (AOR 1.26, 95% CI 1.19-1.32), and parent screen use (AOR 1.11, 95% CI 1.02-1.20) were positively associated with playing mature-rated video games. Greater parental monitoring and limiting of screen time were negatively associated with watching R-rated movies (AOR 0.81, 95% CI 0.77-0.85 and AOR 0.73, 95% CI 0.68-0.79 respectively) and playing mature-rated video games (AOR 0.81, 95% CI 0.77-0.86 and AOR 0.72, 95% CI 0.67-0.77). Restricting screen time as a punishment for misbehavior was linked to a higher odds of watching R-rated movies (AOR 1.06, 95% CI 1.01-1.11) and playing mature-rated video games (AOR 1.12, 95% CI 1.07-1.17) while offering screen time to reward for good behavior was negatively associated with watching R-rated movies (AOR 0.95, 95% CI 0.90-0.99).</p><p><strong>Conclusions: </strong>Media parenting practices such as monitoring or limiting screen use are significantly associated with playing mature-rated video games and watching R-rated movies. Punitive measures, such as restricting screen time as a punishment are slightly associated with increased engagement with such content. These findings highlight the importance of intentional and thoughtful parental strategies in managing children's media consumption effectively.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":"25 1","pages":"90"},"PeriodicalIF":2.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143188254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: The effect of azithromycin treatment on respiratory morbidity in children with down syndrome.
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2025-02-04 DOI: 10.1186/s12887-025-05479-x
Inbal Golan-Tripto, Omer Dor, Noga Arwas, Itai Hazan, Guy Hazan, Aviv Goldbart
{"title":"Correction: The effect of azithromycin treatment on respiratory morbidity in children with down syndrome.","authors":"Inbal Golan-Tripto, Omer Dor, Noga Arwas, Itai Hazan, Guy Hazan, Aviv Goldbart","doi":"10.1186/s12887-025-05479-x","DOIUrl":"https://doi.org/10.1186/s12887-025-05479-x","url":null,"abstract":"","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":"25 1","pages":"92"},"PeriodicalIF":2.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143188258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of β-lactam antibiotic resistance of Escherichia coli isolated from a neonatal intensive care unit.
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2025-02-04 DOI: 10.1186/s12887-025-05389-y
Jian Zhou, Jingqian Zhou, Min Chen, Pan Lü, Chunming Jiang

Introduction: Escherichia coli (E. coli) causes infections in neonates admitted to neonatal intensive care units (NICUs). Although β-lactam antibiotics are commonly used for neonatal infectious diseases, E. coli has exhibited resistance to them. Therefore, we investigated the resistance of E. coli strains isolated from a NICU to β-lactam antibiotics.

Methods: E. coli isolates were collected from patients admitted to a NICU from 2020-2023. The clinical characteristics of the patients were analyzed. The antimicrobial susceptibility was determined using the agar dilution method, and the distribution of β-lactamase genes was analyzed using PCR. Conjugation experiments were conducted to analyze the horizontal transferability of resistance genes on plasmids. Genomic DNA was extracted for whole genome sequencing, construction of plasmid physical maps, locating resistance genes, and analyzing flanking regions and the resistance gene-related sequences.

Results: Throughout the study period, 110 distinct E. coli strains were collected. Among these, 62 cases presented strains, which were resistant against at least one of seven ß-lactam antibiotics associated with conditions such as ventilator-associated pneumonia (35/62), catheter-associated urinary tract infection (14/62), necrotizing enterocolitis (7/62), skin infection (1/62), and neonatal septicemia (5/62). Resistance of E. coli isolates to seven β-lactam antibiotics ranged from 2.73-56.36%. In 62 strains (56.36%, 62/110), six genotypes (11 sub-genotypes) of 111 β-lactamase genes were identified. Conjugation experiments revealed two transconjugants carrying the blaKPC-2 gene and two carrying the blaOXA-1 gene, exhibiting resistance to carbapenems and other β-lactams. The plasmids of four strains were successfully conjugated and transferred to recipient E. coli C600. PCR of the transconjugant resistance genes revealed that two carried a blaKPC-2 gene with a MIC increased up to 32-fold relative to the recipients, and the other two carried a blaOXA-1 gene with a 32-fold increased MIC. For isolate ECK03 carrying blaKPC-2, blaCTX-M-64, blaCTX-M-65, and blaTEM-1, sequencing results showed that blaKPC-2, blaCTX-M-64, and blaTEM-1 were harbored on a 114-kb pECK03_KPC-2 plasmid, whereas two identical blaCTX-M-64 genes were harbored in E. coli isolate ECF13.  CONCLUSION: These findings highlight the existence of E. coli β-lactam resistance within NICU populations, emphasizing the need for continual monitoring of β-lactamase isolates to facilitate effective antibiotic selection.

导言:大肠埃希氏菌(E. coli)是新生儿重症监护室(NICU)中新生儿感染的原因。虽然β-内酰胺类抗生素是治疗新生儿感染性疾病的常用药物,但大肠埃希菌对这些药物具有耐药性。因此,我们研究了从新生儿重症监护室分离的大肠杆菌菌株对β-内酰胺类抗生素的耐药性:方法:从 2020 年至 2023 年期间入住新生儿重症监护室的患者中收集大肠杆菌分离株。分析了患者的临床特征。采用琼脂稀释法测定大肠埃希菌的抗菌药敏感性,并利用 PCR 分析其 β-内酰胺酶基因的分布情况。通过共轭实验分析了质粒上抗性基因的水平转移性。提取基因组 DNA 进行全基因组测序,构建质粒物理图谱,定位抗性基因,分析侧翼区和抗性基因相关序列:结果:在整个研究期间,共收集到 110 株不同的大肠杆菌。结果:在整个研究期间,共收集到 110 株不同的大肠埃希氏菌株,其中 62 个病例的菌株对 7 种ß-内酰胺类抗生素中的至少一种产生耐药性,这些病例与呼吸机相关性肺炎(35/62)、导管相关性尿路感染(14/62)、坏死性小肠结肠炎(7/62)、皮肤感染(1/62)和新生儿败血症(5/62)等疾病相关。大肠杆菌分离株对七种 β-内酰胺类抗生素的耐药性从 2.73% 到 56.36%不等。在 62 株菌株(56.36%,62/110)中,发现了 111 个 β-内酰胺酶基因中的 6 个基因型(11 个亚基因型)。共轭实验发现两株携带 blaKPC-2 基因的转共轭物和两株携带 blaOXA-1 基因的转共轭物对碳青霉烯类和其他 β-内酰胺类药物具有抗性。四株菌株的质粒成功共轭并转入受体大肠杆菌 C600。转共轭抗性基因的聚合酶链式反应(PCR)显示,其中两株携带 blaKPC-2 基因,其 MIC 相对于受体提高了 32 倍,另外两株携带 blaOXA-1 基因,其 MIC 提高了 32 倍。对于携带 blaKPC-2、blaCTX-M-64、blaCTX-M-65 和 blaTEM-1 的分离物 ECK03,测序结果表明 blaKPC-2、blaCTX-M-64 和 blaTEM-1 包藏在一个 114-kb pECK03_KPC-2 质粒上,而两个相同的 blaCTX-M-64 基因则包藏在大肠杆菌分离物 ECF13 中。 结论:这些发现突显了新生儿重症监护病房人群中存在大肠杆菌的β-内酰胺耐药性,强调了持续监控β-内酰胺酶分离物的必要性,以促进有效的抗生素选择。
{"title":"Prevalence of β-lactam antibiotic resistance of Escherichia coli isolated from a neonatal intensive care unit.","authors":"Jian Zhou, Jingqian Zhou, Min Chen, Pan Lü, Chunming Jiang","doi":"10.1186/s12887-025-05389-y","DOIUrl":"10.1186/s12887-025-05389-y","url":null,"abstract":"<p><strong>Introduction: </strong>Escherichia coli (E. coli) causes infections in neonates admitted to neonatal intensive care units (NICUs). Although β-lactam antibiotics are commonly used for neonatal infectious diseases, E. coli has exhibited resistance to them. Therefore, we investigated the resistance of E. coli strains isolated from a NICU to β-lactam antibiotics.</p><p><strong>Methods: </strong>E. coli isolates were collected from patients admitted to a NICU from 2020-2023. The clinical characteristics of the patients were analyzed. The antimicrobial susceptibility was determined using the agar dilution method, and the distribution of β-lactamase genes was analyzed using PCR. Conjugation experiments were conducted to analyze the horizontal transferability of resistance genes on plasmids. Genomic DNA was extracted for whole genome sequencing, construction of plasmid physical maps, locating resistance genes, and analyzing flanking regions and the resistance gene-related sequences.</p><p><strong>Results: </strong>Throughout the study period, 110 distinct E. coli strains were collected. Among these, 62 cases presented strains, which were resistant against at least one of seven ß-lactam antibiotics associated with conditions such as ventilator-associated pneumonia (35/62), catheter-associated urinary tract infection (14/62), necrotizing enterocolitis (7/62), skin infection (1/62), and neonatal septicemia (5/62). Resistance of E. coli isolates to seven β-lactam antibiotics ranged from 2.73-56.36%. In 62 strains (56.36%, 62/110), six genotypes (11 sub-genotypes) of 111 β-lactamase genes were identified. Conjugation experiments revealed two transconjugants carrying the bla<sub>KPC-2</sub> gene and two carrying the bla<sub>OXA-1</sub> gene, exhibiting resistance to carbapenems and other β-lactams. The plasmids of four strains were successfully conjugated and transferred to recipient E. coli C600. PCR of the transconjugant resistance genes revealed that two carried a bla<sub>KPC-2</sub> gene with a MIC increased up to 32-fold relative to the recipients, and the other two carried a bla<sub>OXA-1</sub> gene with a 32-fold increased MIC. For isolate ECK03 carrying bla<sub>KPC-2</sub>, bla<sub>CTX-M-64</sub>, bla<sub>CTX-M-65</sub>, and bla<sub>TEM-1</sub>, sequencing results showed that bla<sub>KPC-2</sub>, bla<sub>CTX-M-64</sub>, and bla<sub>TEM-1</sub> were harbored on a 114-kb pECK03_KPC-2 plasmid, whereas two identical bla<sub>CTX-M-64</sub> genes were harbored in E. coli isolate ECF13.  CONCLUSION: These findings highlight the existence of E. coli β-lactam resistance within NICU populations, emphasizing the need for continual monitoring of β-lactamase isolates to facilitate effective antibiotic selection.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":"25 1","pages":"95"},"PeriodicalIF":2.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143188305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subclinical systolic dysfunction in children with steroid-resistant nephrotic syndrome identified by speckle tracking echocardiography. 通过斑点追踪超声心动图发现类固醇耐受性肾病综合征患儿的亚临床收缩功能障碍。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2025-02-04 DOI: 10.1186/s12887-025-05449-3
Mohamed Hashem Mahgoob, Amr Mostafa Setouhi

Background: Steroid resistant nephrotic syndrome (SRNS) is a clinical phenotype of nephrotic syndrome (NS) that does not respond to steroid therapy and usually results in kidney failure. The aim of this study was to determine whether children with SRNS have subclinical left ventricular systolic dysfunction and, if so, to identify the risk factors for myocardial involvement in those children.

Methods: This prospective case-control study included of 35 children with SRNS, 40 children in the healthy control group, and 40 children with NS during the initial episode as the diseased control group. Conventional echocardiography, tissue Doppler imaging (TDI), and speckle tracking echocardiography (STE) were performed on all the studied children.

Results: No statistically significant difference in conventional echocardiography's parameters were detected between the patient and control groups. TDI revealed that the E/E' ratio was significantly greater in the SRNS group than in both the healthy and diseased control groups (P = 0.001). The left ventricle global longitudinal strain (LV GLS) was markedly lower in children with SRNS than in healthy controls and NS patients (the diseased controls) (P = 0.001). Multiple binary regression analysis for the predictors of systolic dysfunction in SRNS patients revealed that the serum albumin is the only variable that predicts systolic dysfunction in these children.

Conclusions: Subclinical systolic and diastolic LV dysfunction should be screened in NS especially SRNS children.

背景:类固醇耐药肾病综合征(SRNS)是肾病综合征(NS)的一种临床表型,对类固醇治疗无效,通常会导致肾衰竭。本研究旨在确定SRNS患儿是否存在亚临床左心室收缩功能障碍,如果存在,则确定这些患儿心肌受累的危险因素:这项前瞻性病例对照研究包括35名SRNS患儿、40名健康对照组患儿和40名初次发病的NS患儿作为疾病对照组。所有研究对象均接受了常规超声心动图、组织多普勒成像(TDI)和斑点追踪超声心动图(STE)检查:结果:患者组和对照组的常规超声心动图参数无明显统计学差异。TDI显示,SRNS组的E/E'比值明显高于健康组和疾病对照组(P = 0.001)。SRNS患儿的左心室整体纵向应变(LV GLS)明显低于健康对照组和NS患者(疾病对照组)(P = 0.001)。SRNS患者收缩功能障碍预测因素的多元二元回归分析显示,血清白蛋白是预测这些儿童收缩功能障碍的唯一变量:结论:应筛查 NS 尤其是 SRNS 儿童的亚临床收缩和舒张左心室功能障碍。
{"title":"Subclinical systolic dysfunction in children with steroid-resistant nephrotic syndrome identified by speckle tracking echocardiography.","authors":"Mohamed Hashem Mahgoob, Amr Mostafa Setouhi","doi":"10.1186/s12887-025-05449-3","DOIUrl":"https://doi.org/10.1186/s12887-025-05449-3","url":null,"abstract":"<p><strong>Background: </strong>Steroid resistant nephrotic syndrome (SRNS) is a clinical phenotype of nephrotic syndrome (NS) that does not respond to steroid therapy and usually results in kidney failure. The aim of this study was to determine whether children with SRNS have subclinical left ventricular systolic dysfunction and, if so, to identify the risk factors for myocardial involvement in those children.</p><p><strong>Methods: </strong>This prospective case-control study included of 35 children with SRNS, 40 children in the healthy control group, and 40 children with NS during the initial episode as the diseased control group. Conventional echocardiography, tissue Doppler imaging (TDI), and speckle tracking echocardiography (STE) were performed on all the studied children.</p><p><strong>Results: </strong>No statistically significant difference in conventional echocardiography's parameters were detected between the patient and control groups. TDI revealed that the E/E' ratio was significantly greater in the SRNS group than in both the healthy and diseased control groups (P = 0.001). The left ventricle global longitudinal strain (LV GLS) was markedly lower in children with SRNS than in healthy controls and NS patients (the diseased controls) (P = 0.001). Multiple binary regression analysis for the predictors of systolic dysfunction in SRNS patients revealed that the serum albumin is the only variable that predicts systolic dysfunction in these children.</p><p><strong>Conclusions: </strong>Subclinical systolic and diastolic LV dysfunction should be screened in NS especially SRNS children.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":"25 1","pages":"91"},"PeriodicalIF":2.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143188340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMC Pediatrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1